Patient medication - pomalyst 3MG caps.
Ended Awarded Last action
- Contract number
- 36C24526N0367
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,888
Award facts
- Contract value 100% obligated
- $10,887.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company received a delivery order award from Veterans Integrated Service Network 5 (VISN 5) for Pomalyst 3mg capsules, a specialty oncology pharmaceutical used in cancer treatment. The contract, awarded on February 26, 2026, carries a ceiling value of $10,887.52 with a firm fixed-price structure and an ultimate completion date of March 6, 2026. This delivery order was issued under Bristol-Myers Squibb's Federal Supply Schedule contract (ID: 36F79724D0101) for Pharmaceuticals and Drugs (FSS-61-IB) with the Department of Veterans Affairs, a master agreement with a substantial ceiling value of $12.28 billion extending through April 30, 2029. The contract carries no set-aside designation, reflecting Bristol-Myers Squibb's status as a large biopharmaceutical manufacturer.
This award supports the VA's mission to provide advanced oncology treatments to eligible veterans within its healthcare system. Bristol-Myers Squibb, a global biopharmaceutical company headquartered in Lawrenceville, New Jersey, specializes in innovative cancer therapies and immunotherapy treatments. The company has received numerous delivery orders across multiple Veterans Integrated Service Networks since 2022, demonstrating sustained federal demand for its specialized oncology and cell therapy products. Performance of contract work is conducted at the company's Lawrenceville facility, with the product delivery location at the Memphis, Tennessee VA medical center.
Quick answers
Who was awarded contract 36C24526N0367?
36C24526N0367 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 26, 2026.
How much is contract 36C24526N0367 worth?
The government has obligated $10,888 on 36C24526N0367.
Is contract 36C24526N0367 an order under another contract?
Yes. 36C24526N0367 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0367 competed?
The extent of competition for 36C24526N0367 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award